Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
28.50
-1.07 (-3.62%)
Nov 28, 2025, 11:26 AM EST - Market open
Septerna Revenue
Septerna had revenue of $21.50M in the quarter ending September 30, 2025, with 12,113.07% growth. This brings the company's revenue in the last twelve months to $22.05M, up 2,147.20% year-over-year. In the year 2024, Septerna had annual revenue of $1.08M with 611.92% growth.
Revenue (ttm)
$22.05M
Revenue Growth
+2,147.20%
P/S Ratio
55.33
Revenue / Employee
$293,933
Employees
75
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08M | 924.00K | 611.92% |
| Dec 31, 2023 | 151.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSEPN News
- 3 days ago - Septerna to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 3 days ago - Septerna's Novo Partnership Begins To Transform The Story - Seeking Alpha
- 18 days ago - Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 25 days ago - Septerna to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors - GlobeNewsWire
- 3 months ago - Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases - GlobeNewsWire
- 3 months ago - Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside - Benzinga